| Literature DB >> 34715332 |
Gladys Prado1, Elisa Teixeira Mendes2, Roberta Cristina Ruedas Martins1, Lauro Vieira Perdigão-Neto1, Maristela Pinheiro Freire3, Ana Paula Marchi1, Marina Farrel Côrtes1, Victor Augusto Camarinha de Castro Lima1, Flavia Rossi4, Thais Guimarães3, Anna Sara Levin5, Silvia Figueiredo Costa5.
Abstract
Serratia marcescens is an emerging opportunistic pathogen with high genetic diversity. This article describes the microbiological characteristics of isolates and the risk factors for infections caused by carbapenem-resistant S. marcescens. A retrospective study of patients colonized (n=43) and infected (n=20) with carbapenem-resistant S. marcescens over a 3-year period was conducted. Polymerase chain reaction for carbapenemase genes and molecular typing of all available strains was performed. Forty-two isolates were analysed, including three environmental samples identified during an outbreak. Thirty-five carbapenem-resistant S. marcescens carried blaKPC-2, one isolate was blaNDM-positive and four isolates carried blaOXA-101. The genomes were grouped into three clusters with 100% bootstrap; three patterns of mutations on ompC and ompF were found. The strains carried virulence genes related to invasion and haemolysis, and the environmental strains presented fewer mutations on the virulence genes than the clinical strains. Multi-variate analysis showed that previous use of polymyxin (P=0.008) was an independent risk factor for carbapenem-resistant S. marcescens infection. This study highlighted that blaKPC-2 in association with ompC or ompF mutation was the most common mechanism of resistance in the study hospital, and that previous use of polymyxin was an independent risk factor for carbapenem-resistant S. marcescens. There was a predominant clone, including the environmental isolates, suggesting that cross-transmission was involved in the dissemination of this pathogen.Entities:
Keywords: Carbapenem-resistant Serratia marcescens; KPC; NDM; Serratia marcescens
Mesh:
Year: 2021 PMID: 34715332 DOI: 10.1016/j.ijantimicag.2021.106463
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN: 0924-8579 Impact factor: 5.283